Expression of Concern on “The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone”

المصدر

Journal of Diabetes Research

العدد

المجلد 2019، العدد 2019 (31 ديسمبر/كانون الأول 2019)، ص ص. 1-2، 2ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2019-06-16

دولة النشر

مصر

عدد الصفحات

2

التخصصات الرئيسية

الأمراض
الطب البشري

الملخص EN

Journal of Diabetes Research would like to express concern with the article titled “The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone” [1].

After issues were raised by several different parties [2–4] and we consulted editors, concerns were found with conflicts of interest, the nature of the therapy as related to homeopathy, text reuse from other authors, and the methods and reporting.

Details are as follows.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

2019. Expression of Concern on “The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone”. Journal of Diabetes Research،Vol. 2019, no. 2019, pp.1-2.
https://search.emarefa.net/detail/BIM-1172866

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Expression of Concern on “The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone”. Journal of Diabetes Research No. 2019 (2019), pp.1-2.
https://search.emarefa.net/detail/BIM-1172866

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Expression of Concern on “The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone”. Journal of Diabetes Research. 2019. Vol. 2019, no. 2019, pp.1-2.
https://search.emarefa.net/detail/BIM-1172866

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1172866